Canada has placed an order for over 50 million doses from GlaxoSmithKline, their Canadian plant. The government has budgeted $2.7 million for safety and effectiveness studies.
Announcements by Leona Aglukkaq, Minister of Health, and PHAC.

Clinical trials in September-October and vaccinations available in November. The federal government will cover 60% of the cost, and the rest will be borne by the provinces and territories.
Information at www.fightflu.ca

In the States, Baxter International (Illinois) is in full production.
I have not checked for U. S. programs.